Quality of life after complete lymphadenectomy for vulvar cancer: do women prefer sentinel lymph node biopsy?
Identifieur interne : 001603 ( PubMed/Corpus ); précédent : 001602; suivant : 001604Quality of life after complete lymphadenectomy for vulvar cancer: do women prefer sentinel lymph node biopsy?
Auteurs : Rhonda Farrell ; Val Gebski ; Neville F. HackerSource :
- International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [ 1525-1438 ] ; 2014.
English descriptors
- KwdEn :
- Adult, Aged, Aged, 80 and over, Carcinoma, Squamous Cell (complications), Carcinoma, Squamous Cell (psychology), Carcinoma, Squamous Cell (surgery), Choice Behavior, Female, Follow-Up Studies, Humans, Lymph Node Excision (adverse effects), Lymphedema (diagnosis), Lymphedema (etiology), Lymphedema (psychology), Middle Aged, Neoplasm Staging, Postoperative Complications (diagnosis), Postoperative Complications (etiology), Postoperative Complications (psychology), Prognosis, Quality of Life, Sentinel Lymph Node Biopsy (utilization), Surveys and Questionnaires, Vulvar Neoplasms (complications), Vulvar Neoplasms (psychology), Vulvar Neoplasms (surgery).
- MESH :
- adverse effects : Lymph Node Excision.
- complications : Carcinoma, Squamous Cell, Vulvar Neoplasms.
- diagnosis : Lymphedema, Postoperative Complications.
- etiology : Lymphedema, Postoperative Complications.
- psychology : Carcinoma, Squamous Cell, Lymphedema, Postoperative Complications, Vulvar Neoplasms.
- surgery : Carcinoma, Squamous Cell, Vulvar Neoplasms.
- utilization : Sentinel Lymph Node Biopsy.
- Adult, Aged, Aged, 80 and over, Choice Behavior, Female, Follow-Up Studies, Humans, Middle Aged, Neoplasm Staging, Prognosis, Quality of Life, Surveys and Questionnaires.
Abstract
Leg lymphoedema occurs in up to 60% of women after a complete inguinal-femoral lymphadenectomy for vulvar cancer. To avoid lymphoedema, sentinel lymph node biopsy has become the preferred method of staging. However, false-negative results may influence survival, making the sentinel node procedure unacceptable to many fully informed women. The aims of this study were to measure the quality of life (QoL) in women after a complete lymphadenectomy for vulvar cancer and to quantify the risk to survival these women would be prepared to take with sentinel node biopsy.
DOI: 10.1097/IGC.0000000000000101
PubMed: 24662129
Links to Exploration step
pubmed:24662129Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Quality of life after complete lymphadenectomy for vulvar cancer: do women prefer sentinel lymph node biopsy?</title><author><name sortKey="Farrell, Rhonda" sort="Farrell, Rhonda" uniqKey="Farrell R" first="Rhonda" last="Farrell">Rhonda Farrell</name><affiliation><nlm:affiliation>*Royal Hospital for Women, University of New South Wales; and †University of Sydney National Health and Medical Research Council Clinical Trials Centre, Sydney, New South Wales, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Gebski, Val" sort="Gebski, Val" uniqKey="Gebski V" first="Val" last="Gebski">Val Gebski</name></author><author><name sortKey="Hacker, Neville F" sort="Hacker, Neville F" uniqKey="Hacker N" first="Neville F" last="Hacker">Neville F. Hacker</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2014">2014</date><idno type="RBID">pubmed:24662129</idno><idno type="pmid">24662129</idno><idno type="doi">10.1097/IGC.0000000000000101</idno><idno type="wicri:Area/PubMed/Corpus">001603</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001603</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Quality of life after complete lymphadenectomy for vulvar cancer: do women prefer sentinel lymph node biopsy?</title><author><name sortKey="Farrell, Rhonda" sort="Farrell, Rhonda" uniqKey="Farrell R" first="Rhonda" last="Farrell">Rhonda Farrell</name><affiliation><nlm:affiliation>*Royal Hospital for Women, University of New South Wales; and †University of Sydney National Health and Medical Research Council Clinical Trials Centre, Sydney, New South Wales, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Gebski, Val" sort="Gebski, Val" uniqKey="Gebski V" first="Val" last="Gebski">Val Gebski</name></author><author><name sortKey="Hacker, Neville F" sort="Hacker, Neville F" uniqKey="Hacker N" first="Neville F" last="Hacker">Neville F. Hacker</name></author></analytic><series><title level="j">International journal of gynecological cancer : official journal of the International Gynecological Cancer Society</title><idno type="eISSN">1525-1438</idno><imprint><date when="2014" type="published">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Carcinoma, Squamous Cell (complications)</term><term>Carcinoma, Squamous Cell (psychology)</term><term>Carcinoma, Squamous Cell (surgery)</term><term>Choice Behavior</term><term>Female</term><term>Follow-Up Studies</term><term>Humans</term><term>Lymph Node Excision (adverse effects)</term><term>Lymphedema (diagnosis)</term><term>Lymphedema (etiology)</term><term>Lymphedema (psychology)</term><term>Middle Aged</term><term>Neoplasm Staging</term><term>Postoperative Complications (diagnosis)</term><term>Postoperative Complications (etiology)</term><term>Postoperative Complications (psychology)</term><term>Prognosis</term><term>Quality of Life</term><term>Sentinel Lymph Node Biopsy (utilization)</term><term>Surveys and Questionnaires</term><term>Vulvar Neoplasms (complications)</term><term>Vulvar Neoplasms (psychology)</term><term>Vulvar Neoplasms (surgery)</term></keywords><keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Lymph Node Excision</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Carcinoma, Squamous Cell</term><term>Vulvar Neoplasms</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Lymphedema</term><term>Postoperative Complications</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Lymphedema</term><term>Postoperative Complications</term></keywords><keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Carcinoma, Squamous Cell</term><term>Lymphedema</term><term>Postoperative Complications</term><term>Vulvar Neoplasms</term></keywords><keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Carcinoma, Squamous Cell</term><term>Vulvar Neoplasms</term></keywords><keywords scheme="MESH" qualifier="utilization" xml:lang="en"><term>Sentinel Lymph Node Biopsy</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Choice Behavior</term><term>Female</term><term>Follow-Up Studies</term><term>Humans</term><term>Middle Aged</term><term>Neoplasm Staging</term><term>Prognosis</term><term>Quality of Life</term><term>Surveys and Questionnaires</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Leg lymphoedema occurs in up to 60% of women after a complete inguinal-femoral lymphadenectomy for vulvar cancer. To avoid lymphoedema, sentinel lymph node biopsy has become the preferred method of staging. However, false-negative results may influence survival, making the sentinel node procedure unacceptable to many fully informed women. The aims of this study were to measure the quality of life (QoL) in women after a complete lymphadenectomy for vulvar cancer and to quantify the risk to survival these women would be prepared to take with sentinel node biopsy.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24662129</PMID><DateCreated><Year>2014</Year><Month>04</Month><Day>23</Day></DateCreated><DateCompleted><Year>2015</Year><Month>02</Month><Day>13</Day></DateCompleted><DateRevised><Year>2015</Year><Month>11</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1525-1438</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>4</Issue><PubDate><Year>2014</Year><Month>May</Month></PubDate></JournalIssue><Title>International journal of gynecological cancer : official journal of the International Gynecological Cancer Society</Title><ISOAbbreviation>Int. J. Gynecol. Cancer</ISOAbbreviation></Journal><ArticleTitle>Quality of life after complete lymphadenectomy for vulvar cancer: do women prefer sentinel lymph node biopsy?</ArticleTitle><Pagination><MedlinePgn>813-9</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/IGC.0000000000000101</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Leg lymphoedema occurs in up to 60% of women after a complete inguinal-femoral lymphadenectomy for vulvar cancer. To avoid lymphoedema, sentinel lymph node biopsy has become the preferred method of staging. However, false-negative results may influence survival, making the sentinel node procedure unacceptable to many fully informed women. The aims of this study were to measure the quality of life (QoL) in women after a complete lymphadenectomy for vulvar cancer and to quantify the risk to survival these women would be prepared to take with sentinel node biopsy.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">Sixty women who had a complete lymphadenectomy for early-stage vulvar cancer participated in structured interviews. The severity of lymphoedema symptoms was recorded. The QoL-adjusted survival was measured using the Utility-Based Questionnaire-Cancer, a cancer-specific validated QoL instrument. The women stated their preference for sentinel node biopsy or complete lymphadenectomy. A "standard-gamble" preference table was used to quantify the degree of risk to survival they would take to avoid lymphoedema.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Seventy-three percent of women reported lymphoedema after complete lymphadenectomy. Women with lymphoedema or leg pain had significantly worse scores for QoL in terms of social activity as well as physical and sexual function. Overall, 80% of women would choose complete lymphadenectomy rather than sentinel node biopsy if the risk of missing a positive lymph node was higher than 1 in 100, but if the risk of missing a positive lymph node was lower than 1 in 100, almost one third of the women would prefer sentinel node biopsy.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Although women treated for early-stage vulvar cancer report reduced QoL after complete lymphadenectomy, most would choose complete lymphadenectomy over sentinel node biopsy. However, there is an individual level of risk that each woman can define with regard to her preference for the sentinel node procedure. Women with early-stage vulvar cancer should be offered an informed choice between complete lymphadenectomy or sentinel node biopsy.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Farrell</LastName><ForeName>Rhonda</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>*Royal Hospital for Women, University of New South Wales; and †University of Sydney National Health and Medical Research Council Clinical Trials Centre, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gebski</LastName><ForeName>Val</ForeName><Initials>V</Initials></Author><Author ValidYN="Y"><LastName>Hacker</LastName><ForeName>Neville F</ForeName><Initials>NF</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Int J Gynecol Cancer</MedlineTA><NlmUniqueID>9111626</NlmUniqueID><ISSNLinking>1048-891X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002294" MajorTopicYN="N">Carcinoma, Squamous Cell</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002755" MajorTopicYN="Y">Choice Behavior</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008197" MajorTopicYN="N">Lymph Node Excision</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009367" MajorTopicYN="N">Neoplasm Staging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D021701" MajorTopicYN="N">Sentinel Lymph Node Biopsy</DescriptorName><QualifierName UI="Q000656" MajorTopicYN="Y">utilization</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014846" MajorTopicYN="N">Vulvar Neoplasms</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>3</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>3</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24662129</ArticleId><ArticleId IdType="doi">10.1097/IGC.0000000000000101</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001603 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 001603 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:24662129
|texte= Quality of life after complete lymphadenectomy for vulvar cancer: do women prefer sentinel lymph node biopsy?
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:24662129" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |